Authors:
FIBBI G
PUCCI M
SERNI U
CERINIC MM
DELROSSO M
Citation: G. Fibbi et al., ANTISENSE TARGETING OF THE UROKINASE RECEPTOR BLOCKS UROKINASE-DEPENDENT PROLIFERATION, CHEMOINVASION, AND CHEMOTAXIS OF HUMAN SYNOVIAL-CELLS AND CHONDROCYTES IN-VITRO, Proceedings of the Association of American Physicians, 110(4), 1998, pp. 340-350
Authors:
LEMMEL EM
REID DM
NUKI G
AVOUAC B
BARDIN T
BOUVENOT G
CAUWENBERGE H
CLUZEL M
DEVOLGELAER JP
DUFF GW
EMERY P
ETHGEN D
KREUTZ G
MENKES CJ
REIDEL H
SERNI U
VANDERAUWERA P
VEYS E
WHITEGUAY B
REGINSTER JY
Citation: Em. Lemmel et al., RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS USED IN THE TREATMENT OF RHEUMATOID-ARTHRITIS, British journal of rheumatology, 37(2), 1998, pp. 211-215
Authors:
BARTOLONI A
STROHMEYER M
SABATINELLI G
BENUCCI M
SERNI U
PARADISI F
Citation: A. Bartoloni et al., FALSE-POSITIVE PARASIGHT(TM)-F TEST FOR MALARIA IN PATIENTS WITH RHEUMATOID-FACTOR, Transactions of the Royal Society of Tropical Medicine and Hygiene, 92(1), 1998, pp. 33-34
Authors:
ADAMI S
BUFALINO L
CERVETTI R
DIMARCO C
DIMUNNO O
FANTASIA L
ISAIA GC
SERNI U
VECCHIET L
PASSERI M
CASTIGLIONE GN
GARDINI F
LETIZIA G
OCCHIPINTI L
PARDINI N
AGAMENNONE M
SCIOLLA A
MATUCCI A
RIBOLDI R
COSTI D
DALLAGLIO E
PEDRAZZONI M
Citation: S. Adami et al., IPRIFLAVONE PREVENTS RADIAL BONE LOSS IN POSTMENOPAUSAL WOMEN WITH LOW BONE MASS OVER 2 YEARS, Osteoporosis international, 7(2), 1997, pp. 119-125
Authors:
GENNARI C
ADAMI S
AGNUSDEI D
BUFALINO L
CERVETTI R
CREPALDI G
DIMARCO C
DIMUNNO O
FANTASIA L
ISAIA GC
MAZZUOLI GF
ORTOLANI S
PASSERI M
SERNI U
VECCHIET L
Citation: C. Gennari et al., EFFECT OF CHRONIC TREATMENT WITH IPRIFLAVONE IN POSTMENOPAUSAL WOMEN WITH LOW BONE MASS, Calcified tissue international, 61, 1997, pp. 19-22
Authors:
DOUGADOS M
DEVOGELAER JP
ANNEFELDT M
AVOUAC B
BOUVENOT G
COOPER C
DIEPPE P
ETHGEN D
GARATTINI S
JONES EA
KAUFMAN JM
LEEMING M
LEMMEL EM
LOHMANDER S
MENKES CJ
NUKI G
PAOLOZZI L
PUJOL JP
ROVATI L
SERNI U
SPECTOR T
TSOUDEROS Y
VEYS EM
WESELOH G
REGINSTER JY
Citation: M. Dougados et al., RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS USED IN THE TREATMENT OF OSTEOARTHRITIS, Annals of the Rheumatic Diseases, 55(8), 1996, pp. 552-557
Authors:
PASERO G
MARCOLONGO R
SERNI U
PARNHAM MJ
FERRER F
Citation: G. Pasero et al., A MULTICENTER, DOUBLE-BLIND COMPARATIVE-STUDY OF THE EFFICACY AND SAFETY OF ACECLOFENAC AND DICLOFENAC IN THE TREATMENT OF RHEUMATOID-ARTHRITIS, Current medical research and opinion, 13(6), 1995, pp. 305-315
Authors:
FIBBI G
SERNI U
MATUCCI A
MANNONI A
PUCCI M
ANICHINI E
DELROSSO M
Citation: G. Fibbi et al., CONTROL OF THE CHONDROCYTE FIBRINOLYTIC BALANCE BY THE DRUG PIROXICAM- RELEVANCE TO THE OSTEOARTHRITIC PROCESS, Journal of rheumatology, 21(12), 1994, pp. 2322-2328
Authors:
PASERO G
RUJU G
MARCOLONGO R
SENESI M
SERNI U
MANNONI A
ACCARDO S
SERIOLO B
COLOMBO B
LIGNIERE GC
CONSOLI G
DESANTIS D
FERRI S
AMORESANO C
FRIZZIERO L
RETA M
GIORGIANNI G
MARTORANA U
TERMINE S
MATTARA L
FRANCESCHINI M
ORIENTE P
SCARPA R
PERPIGNANO G
BOGLIOLO A
TORRI G
TROTTA F
GOVONI F
Citation: G. Pasero et al., ACECLOFENAC VERSUS NAPROXEN IN THE TREATMENT OF ANKYLOSING-SPONDYLITIS - A DOUBLE-BLIND, CONTROLLED-STUDY, Current therapeutic research, 55(7), 1994, pp. 833-842
Authors:
MANNONI A
ALTMAN RD
MUNIZ OE
SERNI U
DEAN DD
Citation: A. Mannoni et al., THE EFFECTS OF METHOTREXATE ON NORMAL AND OSTEOARTHRITIC LAPINE ARTICULAR-CARTILAGE, Journal of rheumatology, 20(5), 1993, pp. 849-855